A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.
After hours: January 31 at 4:40:34 PM EST Loading Chart for RBBN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback